JP2023552724A5 - - Google Patents
Info
- Publication number
- JP2023552724A5 JP2023552724A5 JP2023530945A JP2023530945A JP2023552724A5 JP 2023552724 A5 JP2023552724 A5 JP 2023552724A5 JP 2023530945 A JP2023530945 A JP 2023530945A JP 2023530945 A JP2023530945 A JP 2023530945A JP 2023552724 A5 JP2023552724 A5 JP 2023552724A5
- Authority
- JP
- Japan
- Prior art keywords
- domain
- transmembrane domain
- cells
- seq
- intracellular signaling
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063117861P | 2020-11-24 | 2020-11-24 | |
| US63/117,861 | 2020-11-24 | ||
| US202163231626P | 2021-08-10 | 2021-08-10 | |
| US63/231,626 | 2021-08-10 | ||
| PCT/US2021/060765 WO2022115565A2 (en) | 2020-11-24 | 2021-11-24 | Chimeric receptors and methods of use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023552724A JP2023552724A (ja) | 2023-12-19 |
| JP2023552724A5 true JP2023552724A5 (https=) | 2024-12-04 |
Family
ID=81756319
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023530945A Pending JP2023552724A (ja) | 2020-11-24 | 2021-11-24 | キメラ受容体及びその使用方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240042027A1 (https=) |
| EP (1) | EP4251644A4 (https=) |
| JP (1) | JP2023552724A (https=) |
| KR (1) | KR20230124912A (https=) |
| AU (1) | AU2021386746A1 (https=) |
| CA (1) | CA3199739A1 (https=) |
| IL (1) | IL303060A (https=) |
| TW (1) | TW202237633A (https=) |
| WO (1) | WO2022115565A2 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024077270A1 (en) * | 2022-10-07 | 2024-04-11 | Senti Biosciences, Inc. | Armed chimeric receptors and methods of use thereof |
| JP2025538171A (ja) * | 2022-11-09 | 2025-11-26 | センティ バイオサイエンシズ インコーポレイテッド | 抗原結合ドメイン及びその使用方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3202419A1 (en) * | 2012-06-06 | 2017-08-09 | OncoMed Pharmaceuticals, Inc. | Pvrig binding agents that modulate the hippo pathway and uses thereof |
| WO2017193059A1 (en) * | 2016-05-06 | 2017-11-09 | The Regents Of The University Of California | Systems and methods for targeting cancer cells |
| US12024715B2 (en) * | 2017-11-07 | 2024-07-02 | Temple University-Of The Commonwealth System Of Higher Education | Compositions and methods for improved T cells |
| WO2020046910A1 (en) * | 2018-08-27 | 2020-03-05 | Figene, Llc | Chimeric antigen receptor fibroblast cells for treatment of cancer |
| BR112021006100A2 (pt) * | 2018-09-28 | 2021-07-20 | Immpact-Bio Ltd. | métodos para identificação de pares de receptor de antígeno ativador (acar)/receptor de antígeno quimérico inibitório (icar) para uso em terapias de câncer |
| WO2020097395A1 (en) * | 2018-11-08 | 2020-05-14 | The Regents Of The University Of California | Systems and methods for targeting cancer cells |
| TW202110873A (zh) * | 2019-04-30 | 2021-03-16 | 美商聖堤生物科技股份有限公司 | 嵌合受體及其使用方法 |
-
2021
- 2021-11-24 JP JP2023530945A patent/JP2023552724A/ja active Pending
- 2021-11-24 AU AU2021386746A patent/AU2021386746A1/en active Pending
- 2021-11-24 WO PCT/US2021/060765 patent/WO2022115565A2/en not_active Ceased
- 2021-11-24 KR KR1020237020602A patent/KR20230124912A/ko active Pending
- 2021-11-24 CA CA3199739A patent/CA3199739A1/en active Pending
- 2021-11-24 TW TW110143787A patent/TW202237633A/zh unknown
- 2021-11-24 EP EP21899095.0A patent/EP4251644A4/en active Pending
- 2021-11-24 IL IL303060A patent/IL303060A/en unknown
-
2023
- 2023-05-24 US US18/201,596 patent/US20240042027A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102879284B1 (ko) | 항-메소텔린 키메라 항원 수용체(car) 작제물 및 이의 용도 | |
| US12029761B2 (en) | Guidance and Navigation Control proteins and method of making and using thereof | |
| KR102763121B1 (ko) | 치료적 면역 세포의 효능의 향상 방법 | |
| JP2019525771A5 (https=) | ||
| JP2018503399A5 (https=) | ||
| JP2023518134A5 (https=) | ||
| US20170015758A1 (en) | Compositions And Methods For Modulating And Redirecting Immune Responses | |
| JP2024023228A5 (https=) | ||
| RU2018135247A (ru) | БИСПЕЦИФИЧЕСКИЕ АНТИТЕЛА К CD25 И Fc ГАММА-РЕЦЕПТОРУ ДЛЯ ЭЛИМИНАЦИИ ОПУХОЛЕСПЕЦИФИЧЕСКИХ КЛЕТОК | |
| AU2021260112B2 (en) | Compositions and methods of treating cancer with chimeric antigen receptors | |
| JP2021513857A5 (https=) | ||
| JP2023515055A5 (https=) | ||
| JP2023552724A5 (https=) | ||
| CA3164042A1 (en) | Compositions and methods of treating cancer with chimeric antigen receptors targeting glypican 3 | |
| CN120035658A (zh) | Nkg2d工程化细胞及其组合物 | |
| JP2023515471A5 (https=) | ||
| CN118891290A (zh) | 细胞免疫疗法的组合物和方法 | |
| US20240042027A1 (en) | Chimeric receptors and methods of use thereof | |
| JP2024541476A5 (https=) | ||
| CN121152813A (zh) | 细胞免疫疗法的组合物和方法 | |
| AU2021317073A1 (en) | Anti-CD22 single domain antibodies and therapeutic constructs | |
| KR20260013488A (ko) | 면역 이펙터 세포 및 이의 용도 | |
| WO2025016450A1 (en) | Combination of cldn18.2 and gucy2c targeted antagonist therapy | |
| CN121548589A (zh) | 细胞免疫疗法的组合物和方法 | |
| CA3233089A1 (en) | Siglec receptor check point inhibitors and method of using them to inhibit neoplastic cell growth |